• A five-year retrospective analysis of patient and graft survival after initial cadaveric kidney transplantation showed that recipients of kidneys from cadaveric donors pretreated with cyclophosphamide (Cytoxan) and methylprednisolone (Medrol) had better graft survival than those patients who received nonpretreated kidneys. In patients not receiving transfusions, transplantation of a pretreated kidney improved the chances of success, with graft survival equivalent to that for patients receiving transfusions. Splenectomy was beneficial for graft survival and did not affect overall patient survival. The effect of splenectomy could not be clearly separated from the effect of donor pretreatment.
(Arch Surg 116:73-77, 1981)
Sterioff S, Zincke H, Waltzer WC, Moore SB, Frohnert PP, Offord KP. Factors Influencing Outcome of Kidney Allografts From Pretreated Cadaveric Donors. Arch Surg. 1981;116(1):73–77. doi:10.1001/archsurg.1981.01380130049011
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: